Csl Ltd has released a press release.
Update on UQ-CSL v451 COVID-19 Vaccine
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Story so far
Earlier from CSL
- Chairmans Address to Shareholders
- CSL Supply Agreement for UQ Vaccine with Commonwealth
- Statutory Accounts for the Full Year Ended 30 June 2020
- CSL to acquire LateStage Gene Therapy Candidate from uniQure
- Change in Leadership of CSLs Finance Function
Later from CSL
- Dividend/Distribution - CSL
- Statutory Accounts for the Half Year Ended 31 Dec 2020
- Update on CSL Agreement with uniQure
- CSL Statutory Accounts for the Full Year Ended 30 June 2021
- Trading Halt
Follow CSL into a list and get an email when it puts out news.
Follow CSL